Milan, April 21, 2020 – NTC Srl, an R&D focused pharmaceutical company headquartered in Italy, has granted license and distribution rights on one of its research and development products, a fixed combination in eye drops, in Mexico to Laboratorios Grin S.A. de C.V, a wholly owned affiliate of Lupin, focused on developing, manufacturing and distributing world-class medicines and a leader in the Ophthalmology segment. 

CPhIWW represents for NTC an important event to create valuable long term business with partners from all over the world.

CPhI Worldwide, 5-7 November 2019.
See you in Frankfurt.